Swedish Orphan Biovitrum AB

(BIOVF)

By |

Profile

Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hemophilia, immunology, and hereditary conditions. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement development programs in 2006. Biovitrum also acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched its hemophilia products Alprolix and Eloctate in Europe in 2016. Sobi recently acquired rights to rare disease drug Gamifant, U.S. rights to Astra's RSV prevention drug Synagis, and rights to thrombocytopenia drug Doptelet (with the Dova acquisition).

Contact Information

Website: www.sobi.com
Email: info@sobi.com
Main Phone: +46 86972000
Address: Tomtebodavagen 23 A
Address 2: Solna
City / Town: Stockholm
Country: SE
Postal Code: SE-112 76

Issuer Information

Exchange: OTO
Employees: 1422

Equities News

Profile

Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hemophilia, immunology, and hereditary conditions. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement development programs in 2006. Biovitrum also acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched its hemophilia products Alprolix and Eloctate in Europe in 2016. Sobi recently acquired rights to rare disease drug Gamifant, U.S. rights to Astra's RSV prevention drug Synagis, and rights to thrombocytopenia drug Doptelet (with the Dova acquisition).

Contact Information

Website: www.sobi.com
Email: info@sobi.com
Main Phone: +46 86972000
Address: Tomtebodavagen 23 A
Address 2: Solna
City / Town: Stockholm
Country: SE
Postal Code: SE-112 76

Issuer Information

Exchange: OTO
Employees: 1422

Equities News

$ 18.68 $ -0.42 (-2.20%)
Last Price 18.68 Change $ -0.42 Change % -2.20 Tick N/A
Bid 18.68 Bid Size 100.00 Ask 19.00 Ask Size 600.00
Open 18.68 High 18.68 Low 18.68 Prev Close 19.10
Last Trade Volume 500 52 Wk Hi 30.00 52 Wk Low 15.64
Market Cap 5.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 303,815,511.00 EPS (TTM) 0.98 PE Ratio 15.70 Exchange OTCPK